(Total Views: 246)
Posted On: 01/10/2024 7:17:38 AM
Post# of 588
Do your d/d and invest WHAT YOU CAN AFFORD TO LOSE! Not to sound totally optimistic but the other board would have you believe total pessimism. Welllll!
AI says and if AI does not know neither does the other board!!
AI states....
I assume you are asking for the latest news on United Health Products, Inc. and its FDA Premarket Approval application. According to a press release by United Health Products, Inc. on December 19, 2022, the company has received and reviewed external laboratory test results on HemoStyp hemostatic gauze produced under its new manufacturing arrangements. The measured physical and chemical characteristics of the new product were shown to be effectively identical to those of the HemoStyp gauze product utilized in the company’s human trial, a key step toward demonstrating a supply of equivalent product for planned commercial production. The company will now incorporate these laboratory results and other data into its PMA application for submission as soon as possible. Concurrently with these final steps for completion of its application, UHP continues to engage with the FDA on various technical aspects of its review process 1.
I hope this information helps. Let me know if you have any other questions.
I'm AI!
AI says and if AI does not know neither does the other board!!
AI states....
I assume you are asking for the latest news on United Health Products, Inc. and its FDA Premarket Approval application. According to a press release by United Health Products, Inc. on December 19, 2022, the company has received and reviewed external laboratory test results on HemoStyp hemostatic gauze produced under its new manufacturing arrangements. The measured physical and chemical characteristics of the new product were shown to be effectively identical to those of the HemoStyp gauze product utilized in the company’s human trial, a key step toward demonstrating a supply of equivalent product for planned commercial production. The company will now incorporate these laboratory results and other data into its PMA application for submission as soon as possible. Concurrently with these final steps for completion of its application, UHP continues to engage with the FDA on various technical aspects of its review process 1.
I hope this information helps. Let me know if you have any other questions.
I'm AI!
(0)
(0)
